Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Deferred Revenue: 2021-2025

Historic Current Deferred Revenue for Core Scientific (CORZ) over the last 3 years, with Sep 2025 value amounting to $2.5 million.

  • Core Scientific's Current Deferred Revenue fell 85.17% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 85.17%. This contributed to the annual value of $349,000 for FY2024, which is 96.44% down from last year.
  • Core Scientific's Current Deferred Revenue amounted to $2.5 million in Q3 2025, which was down 98.33% from $150.1 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Current Deferred Revenue peaked at $1.1 billion during Q4 2021, and registered a low of $349,000 during Q4 2024.
  • Its 3-year average for Current Deferred Revenue is $62.7 million, with a median of $58.3 million in 2024.
  • In the last 5 years, Core Scientific's Current Deferred Revenue crashed by 96.44% in 2024 and then skyrocketed by 298.14% in 2025.
  • Over the past 5 years, Core Scientific's Current Deferred Revenue (Quarterly) stood at $1.1 billion in 2021, then tumbled by 92.60% to $77.7 million in 2022, then plummeted by 87.39% to $9.8 million in 2023, then plummeted by 96.44% to $349,000 in 2024, then plummeted by 85.17% to $2.5 million in 2025.
  • Its Current Deferred Revenue stands at $2.5 million for Q3 2025, versus $150.1 million for Q2 2025 and $60.9 million for Q1 2025.